ClearPoint Neuro, Inc.
Qualité des données : 100%
CLPT
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
8,68 €
▼
0,28 €
(-3,13%)
Cap. Boursière: 267,14 M
Prix
8,98 €
Cap. Boursière
267,14 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Revenue grew 22,72% annually over 5 years — strong growth
Negative free cash flow of -24,45 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,94%
Capital efficient — spends only 1,41% of revenue on capex
Croissance
Revenue Growth (5Y)
22,72%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)17,78%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-143,41%
En dessous de la moyenne du secteur (-53,34%)
ROIC-35,42%
Net Margin-69,08%
Op. Margin-65,36%
Sécurité
Debt / Equity
1,84
Au-dessus de la moyenne du secteur (0,31)
Current Ratio6,37
Interest Coverage-10,12
Valorisation
PE (TTM)
-10,46
En dessous de la moyenne du secteur (-1,47)
P/B Ratio16,83
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -10,5 | -1,5 |
| P/B | 16,8 | 1,6 |
| ROE % | -143,4 | -53,3 |
| Net Margin % | -69,1 | -41,5 |
| Rev Growth 5Y % | 22,7 | 1,8 |
| D/E | 1,8 | 0,3 |
Objectif de Cours des Analystes
2 analystes
Buy
Actuel
8,68 €
Objectif
25,00 €
20,00 €
25,00 €
30,00 €
Prévisions
P/E Prévisionnel
-10,65
BPA Prévisionnel
-0,82 €
CA Est.
63,10 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
-0,82 €
-0,88 € – -0,75 €
|
63,10 M | 2 |
| FY2026 |
-0,97 €
-0,98 € – -0,96 €
|
52,80 M | 2 |
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| 2026 Q2 |
-0,26 €
-0,26 € – -0,25 €
|
12,90 M | 2 |
| 2026 Q1 |
-0,26 €
-0,27 € – -0,25 €
|
12,00 M | 2 |
Surprises de Résultats
Derniers 4 trimestres
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q42025 | -0,20 € | -0,27 € | -35,0% |
| Q32025 | -0,20 € | -0,21 € | -5,0% |
| Q22025 | -0,20 € | -0,21 € | -5,0% |
| Q12025 | -0,16 € | -0,22 € | -37,5% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17,78% | Revenue Growth (3Y) | 24,23% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 22,72% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 36,97 M | Net Income (TTM) | -25,54 M |
| ROE | -143,41% | ROA | -41,45% |
| Gross Margin | 61,38% | Operating Margin | -65,36% |
| Net Margin | -69,08% | Free Cash Flow (TTM) | -24,45 M |
| ROIC | -35,42% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,84 | Current Ratio | 6,37 |
| Interest Coverage | -10,12 | Asset Turnover | 0,60 |
| Working Capital | 43,28 M | Tangible Book Value | 15,87 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -10,46 | Forward P/E | N/A |
| P/B Ratio | 16,83 | P/S Ratio | 7,23 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -9,15% | ||
| Market Cap | 267,14 M | Enterprise Value | 258,12 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,90 | Revenue / Share | 1,24 |
| FCF / Share | -0,82 | OCF / Share | -0,80 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 1,41% | FCF Conversion | 95,72% |
| SBC-Adj. FCF | -32,55 M | Growth Momentum | -4,94 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 36,97 M | 31,39 M | 23,96 M | 20,55 M | 16,30 M |
| Net Income | -25,54 M | -18,91 M | -22,09 M | -16,44 M | -14,41 M |
| EPS (Diluted) | -0,90 | -0,70 | -0,90 | -0,68 | — |
| Gross Profit | 22,69 M | 19,12 M | 13,61 M | 13,53 M | 11,29 M |
| Operating Income | -24,16 M | -19,75 M | -22,45 M | -16,33 M | -13,37 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 13,90 M | 12,39 M | 11,71 M | 10,89 M | 8,99 M |
| SG&A Expenses | 16,50 M | 12,00 M | 11,76 M | 9,61 M | 8,76 M |
| D&A | 814 000,0 | 980 000,0 | 626 000,0 | 244 000,0 | 159 000,0 |
| Interest Expense | 2,39 M | 872 000,0 | 386 000,0 | 81 000,0 | 973 000,0 |
| Income Tax | 55 000,0 | 12 000,0 | 8 000,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 97,75 M | 39,19 M | 42,66 M | 55,49 M | 65,58 M |
| Total Liabilities | 69,73 M | 13,80 M | 21,49 M | 18,60 M | 16,79 M |
| Shareholders' Equity | 28,02 M | 25,39 M | 21,17 M | 36,89 M | 48,79 M |
| Total Debt | 49,08 M | — | 9,95 M | 9,89 M | 9,84 M |
| Cash & Equivalents | 45,92 M | 20,10 M | 23,14 M | 27,62 M | 54,11 M |
| Current Assets | 63,60 M | 33,36 M | 36,17 M | 51,18 M | 61,89 M |
| Current Liabilities | 10,77 M | 10,35 M | 7,43 M | 6,79 M | 4,75 M |
{"event":"ticker_viewed","properties":{"ticker":"CLPT","listing_kind":"stock","pathname":"/stocks/clpt","exchange":"Nasdaq","country":"US"}}